Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS
- Status
- RECRUITING
- Phase
- PHASE2
Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
- Status
- COMPLETED
- Phase
- NA
NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
- Status
- TERMINATED
- Phase
- PHASE1
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy
- Status
- UNKNOWN
- Phase
- PHASE1
Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Universal CAR-T Cells Targeting AML
- Status
- RECRUITING
- Phase
- PHASE1
Universal 4SCAR7U Targeting CD7-positive Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE3
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
- Status
- RECRUITING
- Phase
- PHASE1
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML
- Status
- UNKNOWN
- Phase
- PHASE1
Acute Myeloid Leukemia Registry
- Status
- RECRUITING
- Phase
- N/A